We are live on
!
Find out more
Arrowstreet Capital Portfolio holdings
AUM
$185B
1-Year Est. Return
39.58%
This Fund
S&P 500
This Quarter
Est. Return
+2.2%
1 Year Est. Return
+39.58%
3 Year Est. Return
+145.48%
5 Year Est. Return
+192.07%
10 Year Est. Return
+749.68%
AUM
$43.6B
AUM Growth
+$2.01B
(+4.8%)
Cap. Flow
+$1.75B
Cap. Flow
% of AUM
4%
Top 10 Holdings %
Top 10 Hldgs %
18.28%
Holding
1,493
New
278
Increased
387
Reduced
400
Closed
399
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$674M |
| 2 |
IBM
IBM
|
+$408M |
| 3 |
Toronto Dominion Bank
TD
|
+$392M |
| 4 |
Biogen
BIIB
|
+$340M |
| 5 |
Boeing
BA
|
+$319M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Philip Morris
PM
|
+$366M |
| 2 |
CVS Health
CVS
|
+$350M |
| 3 |
WBA
Walgreens Boots Alliance
WBA
|
+$333M |
| 4 |
TSMC
TSM
|
+$323M |
| 5 |
Merck
MRK
|
+$283M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.47% |
| 2 | Healthcare | 17.17% |
| 3 | Financials | 16.49% |
| 4 | Consumer Discretionary | 12.16% |
| 5 | Industrials | 11.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
376
Macy's
M
$6.68B
| $14.2M | 0.03% |
476,527
+424,627
| +818% | +$11.5M |
|
377
Live Nation Entertainment
LYV
$42.1B
| $14.1M | 0.03% |
334,907
+273,607
| +446% | +$12.1M |
|
|
FLIR
378
DELISTED
FLIR Systems, Inc. (DE) Common Stock
FLIR
| $14M | 0.03% |
280,028
+247,628
| +764% | +$12.3M |
|
379
Nice
NICE
$5.97B
| $13.9M | 0.03% |
+148,212
| New | +$13.8M |
|
380
Silicon Laboratories
SLAB
$7.23B
| $13.9M | 0.03% |
154,351
-76,795
| -33% | -$7.24M |
|
381
Corcept Therapeutics
CORT
$12B
| $13.8M | 0.03% |
836,280
+294,834
| +54% | +$5.46M |
|
382
Builders FirstSource
BLDR
$8.04B
| $13.7M | 0.03% |
692,906
+386,000
| +126% | +$8.17M |
|
|
RENX
383
DELISTED
RELX N.V.
RENX
| $13.7M | 0.03% |
657,836
+141,950
| +28% | +$3.03M |
|
384
Merit Medical Systems
MMSI
$5.32B
| $13.7M | 0.03% |
301,470
+44,250
| +17% | +$2M |
|
|
AVTA
385
DELISTED
Avantax, Inc. Common Stock
AVTA
| $13.6M | 0.03% |
552,931
-72,672
| -12% | -$1.73M |
|
386
Freeport-McMoran
FCX
$97.5B
| $13.6M | 0.03% |
+772,500
| New | +$14.5M |
|
387
Varonis Systems
VRNS
$5B
| $13.5M | 0.03% |
667,995
+384,495
| +136% | +$7.12M |
|
388
Western Union
WU
$2.21B
| $13.4M | 0.03% |
+696,916
| New | +$14M |
|
389
Steven Madden
SHOO
$3.55B
| $13.1M | 0.03% |
+448,421
| New | +$13.5M |
|
390
Fair Isaac
FICO
$22.5B
| $13.1M | 0.03% |
77,383
+22,700
| +42% | +$3.79M |
|
391
Elbit Systems
ESLT
$40.3B
| $13M | 0.03% |
107,939
+28,025
| +35% | +$3.89M |
|
392
Murphy Oil
MUR
$4.78B
| $13M | 0.03% |
502,170
-740,902
| -60% | -$21.4M |
|
393
AdvanSix
ASIX
$444M
| $12.9M | 0.03% |
372,033
+11,905
| +3% | +$469K |
|
394
Orthofix Medical
OFIX
$419M
| $12.9M | 0.03% |
219,615
+195,032
| +793% | +$10.9M |
|
395
iShares Core S&P 500 ETF
IVV
$904B
| $12.7M | 0.03% |
48,000
+18,900
| +65% | +$5.2M |
|
|
GRA
396
DELISTED
W.R. Grace & Co.
GRA
| $12.7M | 0.03% |
207,969
-321,856
| -61% | -$22.1M |
|
397
Pilgrim's Pride
PPC
$6.54B
| $12.7M | 0.03% |
516,076
-1,424,195
| -73% | -$38.2M |
|
398
BJ's Restaurants
BJRI
$1.48B
| $12.5M | 0.03% |
277,728
+266,028
| +2,274% | +$10.7M |
|
399
Green Dot
GDOT
$745M
| $12.3M | 0.03% |
192,122
+55,178
| +40% | +$3.48M |
|
400
Crocs
CROX
$6.55B
| $12.3M | 0.03% |
756,322
+315,248
| +71% | +$4.37M |
|
Similar funds
VGA
Arrowstreet Capital's Q1 2018 Portfolio in Review
As of Q1 2018, Arrowstreet Capital held 1,493 positions worth $43.6B, up 4.8% from $41.6B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Arrowstreet Capital deployed $1.75B of net new capital in Q1 2018, opening 278 new positions and adding to 387 existing holdings. Its largest new stake was AB InBev: 2,063,707 shares worth $227M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 17% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Philip Morris, an estimated $366M trimmed.
- Arrowstreet Capital's largest Q1 2018 buy was AB InBev: 2,063,707 shares worth $227M.
- Arrowstreet Capital added most to AbbVie in Q1 2018, an estimated $674M increase.
- Arrowstreet Capital's biggest Q1 2018 reduction was Philip Morris, cutting an estimated $366M.
- Arrowstreet Capital fully exited iShares MSCI South Korea ETF in Q1 2018, selling an estimated $271M.
- Arrowstreet Capital's ten largest holdings make up 18% of its $43.6B portfolio in Q1 2018.
- Arrowstreet Capital opened 278 new positions and closed 399 in Q1 2018.
- Arrowstreet Capital's portfolio value rose 4.8% quarter-over-quarter to $43.6B.
Based on Arrowstreet Capital's 13F filing for Q1 2018, filed 14 May 2018.